The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease
Open accessAbstract
Human heterophile antibodies that agglutinate animal erythrocytes are known to detect the nonhuman sialic acid N-glycolylneuraminic acid (Neu5Gc). This monosaccharide cannot by itself fill the binding site (paratope) of an antibody and can also be modified and presented in various linkages, on diverse underlying glycans. Thus, we hypothesized that the human anti-Neu5Gc antibody response is diverse and polyclonal. Here, we use a novel set of natural and chemoenzymatically synthesized glycans to show that normal humans have an abundant and diverse spectrum of such anti-Neu5Gc antibodies, directed against a variety of Neu5Gc-containing epitopes. High sensitivity and specificity assays were achieved by using N-acetylneuraminic acid (Neu5Ac)-containing probes (differing from Neu5Gc by one less oxygen atom) as optimal background controls. The commonest anti-Neu5Gc antibodies are of the IgG class. Moreover, the range of reactivity and Ig classes of antibodies vary greatly amongst normal humans, with some individuals having remarkably large amounts, even surpassing levels of some well-known natural blood group and xenoreactive antibodies. We purified these anti-Neu5Gc antibodies from individual human sera using a newly developed affinity method and showed that they bind to wild-type but not Neu5Gc-deficient mouse tissues. Moreover, they bind back to human carcinomas that have accumulated Neu5Gc in vivo. As dietary Neu5Gc is primarily found in red meat and milk products, we suggest that this ongoing antigen-antibody reaction may generate chronic inflammation, possibly contributing to the high frequency of diet-related carcinomas and other diseases in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Clinical and Experimental Immunology
Kay, H. (1966) · PubMed Central · Cited by 2,177
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary Perspective
Angata, T., & Varki, A. (2002) · Chemical Reviews · doi:10.1021/cr000407m · Cited by 1,237
Self-citationHuman uptake and incorporation of an immunogenic nonhuman dietary sialic acid
Tangvoranuntakul, P., Gagneux, P., Diaz, S., Bardor, M., Varki, N., Varki, A., & Muchmore, E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2131556100 · Cited by 625
Self-citationGalili, U., Mandrell, R. E., Hamadeh, R. M., Shohet, S. B., & Griffiss, J. M. (1988) · Infection and Immunity · doi:10.1128/iai.56.7.1730-1737.1988 · Cited by 548
Rose, D. P., Boyar, A. P., & Wynder, E. L. (1986) · Cancer · doi:10.1002/1097-0142(19861201)58:11<2363::aid-cncr2820581102>3.0.co;2-# · Cited by 518
Mucin‐type O ‐glycans in human colon and breast cancer: glycodynamics and functions
Brockhausen, I. (2006) · EMBO reports · doi:10.1038/sj.embor.7400705 · Cited by 511
Meat consumption and colorectal cancer risk: Dose‐response meta‐analysis of epidemiological studies
Norat, T., Lukanova, A., Ferrari, P., & Riboli, E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10126 · Cited by 501
Key, T. J., Fraser, G. E., Thorogood, M., Appleby, P. N., Beral, V., Reeves, G., Burr, M. L., Chang-Claude, J., Frentzel-Beyme, R., Kuzma, J. W., et al. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.516s · Cited by 484
Siber, G. R., Schur, P. H., Aisenberg, A. C., Weitzman, S. A., & Schiffman, G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007243030402 · Cited by 473
Bardor, M., Nguyen, D. H., Diaz, S., & Varki, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412040200 · Cited by 390
Self-citationThe α‐gal epitope and the anti‐Gal antibody in xenotransplantation and in cancer immunotherapy
Galili, U. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01366.x · Cited by 336
The Chemistry and Biology of Sialic Acids and Related Substances
Warren, L., & Gottschalk, A. (1961) · AIBS Bulletin · doi:10.2307/1292661 · Cited by 325
Varki, A. (2001) · American Journal of Physical Anthropology · doi:10.1002/ajpa.10018 · Cited by 324
Self-citationBlood group isoantibody stimulation in man by feeding blood group-active bacteria
Springer, G. F., & Horton, R. E. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106094 · Cited by 317
Inflammation by remote control
Mantovani, A. (2005) · Nature · doi:10.1038/435752a · Cited by 313
Anti‐N‐glycolylneuraminic acid antibodies identified in healthy human serum
Zhu, A., & Hurst, R. (2002) · Xenotransplantation · doi:10.1034/j.1399-3089.2002.02138.x · Cited by 273
Malykh, Y. N., Schauer, R., & Shaw, L. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01303-7 · Cited by 272
THE PATTERN OF MAMMALIAN BRAIN GANGLIOSIDES—III: REGIONAL AND DEVELOPMENTAL DIFFERENCES*
Suzuki, K. (1965) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1965.tb10256.x · Cited by 269
Yu, H., Huang, S., Chokhawala, H., Sun, M., Zheng, H., & Chen, X. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600572 · Cited by 261
Self-citationSequencing the chimpanzee genome: insights into human evolution and disease
Olson, M. V., & Varki, A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg981 · Cited by 245
Self-citationGalili, U., Anaraki, F., Thall, A., Hill-Black, C., & Radic, M. (1993) · Blood · doi:10.1182/blood.v82.8.2485.2485 · Cited by 241
Yu, H., Yu, H., Karpel, R., & Chen, X. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.030 · Cited by 241
Self-citationKobata, A., & Amano, J. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01351.x · Cited by 237
Lewin, M. H., Bailey, N., Bandaletova, T., Bowman, R., Cross, A. J., Pollock, J., Shuker, D. E. G., & Bingham, S. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2237 · Cited by 219
Loss of Siglec expression on T lymphocytes during human evolution
Nguyen, D. H., Hurtado-Ziola, N., Gagneux, P., & Varki, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510484103 · Cited by 204
Self-citationN-Glycolylneuraminic Acid Deficiency in Mice: Implications for Human Biology and Evolution
Hedlund, M., Tangvoranuntakul, P., Takematsu, H., Long, J. M., Housley, G. D., Kozutsumi, Y., Suzuki, A., Wynshaw-Boris, A., Ryan, A. F., Gallo, R. L., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00379-07 · Cited by 196
Self-citationHigashi, H., Naiki, M., Matuo, S., & Ōkouchi, K. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)90169-3 · Cited by 174
Manimala, J. C., Roach, T. A., Li, Z., & Gildersleeve, J. C. (2007) · Glycobiology · doi:10.1093/glycob/cwm047 · Cited by 169
Yin, J., Hashimoto, A., Izawa, M., Miyazaki, K., Chen, G.-Y., Takematsu, H., Kozutsumi, Y., Suzuki, A., Furuhata, K., Cheng, F.-L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2615 · Cited by 160
Yu, H., Chokhawala, H. A., Huang, S., & Chen, X. (2006) · Nature Protocols · doi:10.1038/nprot.2006.401 · Cited by 159
Self-citationNguyen, D. H., Tangvoranuntakul, P., & Varki, A. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.228 · Cited by 145
Self-citationCancer Mortality Surveillance--United States, 1990-2000
Stewart, S. L., King, J., Thompson, T., Friedman, C., & Wingo, P. A. (2004) · PsycEXTRA Dataset · doi:10.1037/e307142005-001 · Cited by 141
Merrick, J. M., Zadarlik, K., & Milgrom, F. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000232140 · Cited by 126
Comparative enzymology, biochemistry and pathophysiology of human exo-α-sialidases (neuraminidases)
Achyuthan, K. E., & Achyuthan, A. M. (2001) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s1096-4959(01)00372-4 · Cited by 123
Hara, S., Yamaguchi, M., Takemori, Y., Nakamura, M., & Ohkura, Y. (1986) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)80766-5 · Cited by 115
Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.
Zhang, S., Walberg, L. A., Ogata, S., Itzkowitz, S. H., Koganty, R. R., Reddish, M. J., Gandhi, S. S., Longenecker, B. M., Lloyd, K. O., & Po, L. (1995) · PubMed · Cited by 104
ABO blood group and related antigens, natural antibodies and transplantation
Milland, J., & Sandrin, M. S. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00721.x · Cited by 97
Über die Erzeugung heterospezifischer Hämagglutinine durch Injektion artfremden Serums
Deicher, H. (1926) · Medical Microbiology and Immunology · doi:10.1007/bf02176298 · Cited by 94
Translational Crossroads for Biomarkers
Bast, R. C., Lilja, H. G., Urban, N. D., Rimm, D. L., Fritsche, H. A., Gray, J. W., Veltri, R. W., Klee, G. G., Allen, A. R., Kim, N., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2213 · Cited by 81
Hanganutziu-Deicher Antigen and Antibody in Pathologic Sera and Tissues
Nishimaki, T., Kano, K., & Milgrom, F. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.6.2314 · Cited by 73
Efficient Metabolic Engineering of GM3 on Tumor Cells by N-Phenylacetyl- d -mannosamine
Chefalo, P. J., Pan, Y., Nagy, N., Guo, Z., & Harding, C. V. (2006) · Biochemistry · doi:10.1021/bi052161r · Cited by 73
Xenotransplantation and ABO incompatible transplantation: The similarities they share
Galili, U. (2006) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2006.05.007 · Cited by 63
Two chicken monoclonal antibodies specific for heterophil Hanganutziu-Deicher antigens
Asaoka, H., Nishinaka, S., Wakamiya, N., Matsuda, H., & Murata, M. (1992) · Immunology Letters · doi:10.1016/0165-2478(92)90205-3 · Cited by 53
Model-building study of the combining sites of two antibodies to alpha (1----6)dextran.
PADLAN, E. A., & Kabat, E. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6885 · Cited by 53
Miyake, M., Ito, M., Hitomï, S., Ikeda, S., Taki, T., Kurata, M., Hino, A., Miyake, N., & Kannagi, R. (1988) · PubMed · Cited by 52
Lee, M. H., Lloyd, P., Zhang, X., Schallhorn, J. M., Sugimoto, K., Leach, A. G., Sapiro, G., & Houk, K. N. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo052659z · Cited by 44
Gerken, T. A., & Jentoft, N. (1987) · Biochemistry · doi:10.1021/bi00389a015 · Cited by 43
Hanganutziu-Deicher antibodies in infectious mononucleosis and other diseases.
Morito, T., Kano, K., & Milgrom, F. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.6.2524 · Cited by 40
Tai, T., Kawashima, I., Koichi, F., & Lloyd, K. O. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90423-7 · Cited by 39
Yu, H., Chokhawala, H. A., Varki, A. P., & Chen, X. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b706507h · Cited by 37
Self-citationTHE HETEROPHILE ANTIBODIES IN INFECTIOUS MONONUCLEOSIS AND AFTER THE INJECTION OF SERUM 1
Beer, P. (1936) · Journal of Clinical Investigation · doi:10.1172/jci100811 · Cited by 34
Hanganutziu-Deicher Antigen as a Possible Target for Immunotherapy of Melanoma
Nakarai, H., Chandler, P. J., Kano, K., Morton, D. L., & Irie, R. F. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235135 · Cited by 26
Survey of Hanganutziu and Deicher Antibodies in Operated Patients
HIGASHIHARA, T., Takeshima, T., Anzai, M., Tomioka, M., Matsumoto, K., Nishida, K., Kitamura, Y., Okinaga, K., & Naiki, M. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235434 · Cited by 25
Immunological studies on Kawasaki disease. I. Appearance of Hanganutziu-Deicher antibodies.
Takiguchi, M., Tamura, T., Goto, M., Kusakawa, S., Milgrom, F., & Kano, K. (1984) · PubMed Central · Cited by 22
Studies on Hanganutziu-Deicher Antigens-Antibodies
MORITO, T., Nishimaki, T., Masaki, M., Yoshida, H., Kasukawa, R., Nakarai, H., & Kano, K. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000234135 · Cited by 19
Mukuria, C. J., Fujii, Y. R., Kato, S., & Naiki, M. (1986) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a121735 · Cited by 10
Amplified ELISA to detect autoantibodies to N-glycolyl-GM3 ganglioside.
Iznaga, N., Carr, A., Fernández, L. E., Solozabal, J., Núñez, G., Perdomo, Y., & Morales, A. (1996) · PubMed · Cited by 4
Cited by
Glycosylation as a strategy to improve antibody-based therapeutics
Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829
“Similarly, CHO, NS0 and Sp2/0 cells can add an α(2–3)-linked N -glycylneuraminic acid that is not present in humans and that might also be immunogeni”
BackgroundMammalian glycosylation in immunity
Marth, J. D., & Grewal, P. K. (2008) · Nature Reviews Immunology · doi:10.1038/nri2417 · Cited by 712
Sialic acids as regulators of molecular and cellular interactions
Schauer, R. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.06.003 · Cited by 673
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Dumont, J., Euwart, D., Mei, B., Estes, S., & Kshirsagar, R. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1084266 · Cited by 483
Liu, L. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24444 · Cited by 428
Metadata
- Authors
- Padler-Karavani, V., Yu, H., Cao, H., Chokhawala, H., Karp, F., Varki, N., Chen, X., & Varki, A.
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-06
- Volume
- 18
- Issue
- 10
- Pages
- 818-830
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- OpenAlex
- W2153180588
- Cited by
- 326
- References
- 59
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.